Detalhe da pesquisa
1.
TGFß Inhibition Stimulates Collagen Maturation to Enhance Bone Repair and Fracture Resistance in a Murine Myeloma Model.
J Bone Miner Res
; 34(12): 2311-2326, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31442332
2.
Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models.
J Bone Miner Res
; 34(5): 783-796, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30320927
3.
The Pharmacological Profile of a Novel Highly Potent Bisphosphonate, OX14 (1-Fluoro-2-(Imidazo-[1,2-α]Pyridin-3-yl)-Ethyl-Bisphosphonate).
J Bone Miner Res
; 32(9): 1860-1869, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28337806
4.
NOD/SCID-GAMMA mice are an ideal strain to assess the efficacy of therapeutic agents used in the treatment of myeloma bone disease.
PLoS One
; 10(3): e0119546, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25768011
5.
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche.
Nat Commun
; 6: 8983, 2015 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26632274